These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34292665)

  • 1. Ascending myelopathy after intrathecal methotrexate.
    Chiu YH; Yang E; Chen YC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):1018-1019. PubMed ID: 34292665
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
    Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
    J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
    Gosavi T; Diong CP; Lim SH
    J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate myelopathy after intrathecal chemotherapy: a case report.
    Murata KY; Maeba A; Yamanegi M; Nakanishi I; Ito H
    J Med Case Rep; 2015 Jun; 9():135. PubMed ID: 26055509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Necrotizing myelopathy after intrathecal methotrexate].
    Sanhes L; Delmer A; Zittoun R
    Presse Med; 1997 May 3-10; 26(15):719. PubMed ID: 9183374
    [No Abstract]   [Full Text] [Related]  

  • 7. Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
    Pinnix CC; Chi L; Jabbour EJ; Milgrom SA; Smith GL; Daver N; Garg N; Cykowski MD; Fuller G; Cachia D; Kamiya-Matsuoka C; Woodman K; Dinardo C; Jain N; Kadia TM; Pemmaraju N; Ohanian M; Konopleva M; Kantarjian HM; Dabaja BS
    Am J Hematol; 2017 Feb; 92(2):155-160. PubMed ID: 27874212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
    Vainionpää L; Kovala T; Tolonen U; Lanning M
    Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated necrotizing leukoencephalopathy].
    Araga S
    Nihon Rinsho; 2004 Jan; 62 Suppl():312-4. PubMed ID: 15011373
    [No Abstract]   [Full Text] [Related]  

  • 10. Myelopathy mimicking subacute combined degeneration in a Down syndrome patient with methotrexate treatment for B lymphoblastic leukemia: report of an autopsy case.
    Satomi K; Yoshida M; Matsuoka K; Okita H; Hosoya Y; Shioda Y; Kumagai MA; Mori T; Morishita Y; Noguchi M; Nakazawa A
    Neuropathology; 2014 Aug; 34(4):414-9. PubMed ID: 24661121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal leukovorin after intrathecal methotrexate overdose.
    Trinkle R; Wu JK
    J Pediatr Hematol Oncol; 1997; 19(3):267-9. PubMed ID: 9201155
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate induced seizures associated with acute reversible magnetic resonance imaging (MRI) changes in a patient with acute lymphoblastic leukemia.
    Rao RD; Swanson JW; Dejesus RS; Hunt CH; Tefferi A
    Leuk Lymphoma; 2002 Jun; 43(6):1333-6. PubMed ID: 12153004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk.
    Juster-Switlyk K; Smith AG; Kovacsovics T; Stephens D; Glenn M; Palmer CA; Quigley EP; Kolb N
    Neurology; 2017 Feb; 88(6):603-604. PubMed ID: 28062724
    [No Abstract]   [Full Text] [Related]  

  • 14. Posterior reversible encephalopathy after intrathecal methotrexate therapy in diffuse large B-cell lymphoma.
    Patel A; Ayto R; MacDonald DH
    Br J Haematol; 2013 Jun; 161(5):607. PubMed ID: 23617825
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral subdural hygromas following intrathecal methotrexate.
    Lokireddy P; Dyer MJ
    Br J Haematol; 2011 Dec; 155(5):536. PubMed ID: 21923656
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of reversible cerebral neurotoxicity and irreversible cerebellar atrophy following an intrathecal methotrexate chemotherapy: two case reports.
    Masterson K; Merlini L; Lövblad KO
    J Neuroradiol; 2009 May; 36(2):112-4. PubMed ID: 18722663
    [No Abstract]   [Full Text] [Related]  

  • 19. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
    Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
    Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
    Sandoval C; Kutscher M; Jayabose S; Tenner M
    AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.